Ask AI
ProCE Banner Activity

Clinical Practice Resource: Diagnosis and Treatment of Alzheimer’s Disease

PDF

This downloadable, print-ready Clinical Practice Resource provides a brief overview of current best practices for the diagnosis and treatment of Alzheimer’s disease. These key points are designed as an easy reference guide for use in the clinic or to share in educating patients and caregivers.

Released: January 12, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Eisai.

Eisai

Target Audience

This activity is intended for neurologists, geriatricians, nurse practitioners, physician associates, psychiatrists, and other healthcare professionals caring for patients with AD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate current evidence and expert recommendations on biomarker testing to support early detection of Alzheimer’s disease pathology

  • Assess the safety and efficacy of newly approved and investigational treatments for Alzheimer’s disease

  • Define the clinical role of novel and emerging therapies in the evolving AD treatment landscape

  • Translate recent clinical trial findings into practice to expand therapeutic options and enhance patient outcomes

  • Identify key benefits and practical considerations of subcutaneous therapy (e.g., SC lecanemab), including administration timing, autoinjector use, and patient training

  • Implement adherence support strategies for patients receiving SC therapy, addressing barriers like needle anxiety, storage logistics, and self-administration confidence

Disclosure

Primary Author

David S. Geldmacher, MD, FANA, FACP: consultant/advisor/speaker: Eisai, Lilly, researcher: Biogen, Janssen, Roche; individual publicly traded stocks/stock options: Doximity.